Return to homepagePandemic Pact

A nanometric sensor -based scent system for the early detection of disease caused by the Coronavirus (COVID-19)

  • Funded by Israel Innovation Authority
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $0

  • Funder

    Israel Innovation Authority

  • Principal Investigator

    N/A

  • Research Location

    Israel

  • Lead Research Institution

    Nanoscent Ltd.

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    N/A

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

A conversion of existing technology based on nanometric sensors in order to monitor people who have been inflicted with COVID -19, through the analysis of the air exhaled through the nose. Validation of the technology and implementation of the initial detection model will be achieved through a multi-center trial and the collection of samples from 1,400 volunteers. Rapid assimilation (up to six months) of the product in the market. Extensive use of the product in places where there is a large gatherings of people can significantly stem the spread of the Coronavirus by segregating people suspected of being disease carriers from healthy people.